Imechapishwa
24.08.2026
Imetuzwa
24.08.2026
Genzyme Corporation
Vivus LLC, 65IB, 36F79726D0185, Performance Period: 09/29/2026 - 09/30/2031
Bausch Health US, LLC Award 09/30/2026 - 09/30/2031
Sumitomo Pharma America, Inc. 09/01/2026 - 08/31/2031
Novum Medical Products of NY, LLC 65IIA, 36F79726D0188 Effective 9/1/2026/Expires 8/31/2031
Americare, LLC. 65IIA Base Period of Performance 09/01/2026 - 08/31/2031
Mesalamine 1200mg Tablet (VA-27-00000768)
Bausch Health US, LLC Award 09/30/2026 - 09/30/2031
Bupropion HCL ER
Philadelphia VA Medical Center Radiopharmacueticals
Philadelphia VA Medical Center Radiopharmacueticals
SNS Pharmaceutical Logistic Replenishment Requirement
© 2026 SIA «Vietne». Haki zote zimehifadhiwa.